News & Events
-
February 16, 2022
C-Path Board Member Dr. Robert Califf Confirmed as New FDA Commissioner
Statement from Critical Path Institute Board Chair Wainwright Fishburn on the Senate Confirmation of Dr. Robert M. Califf, MD, MACC, as Commissioner of the U.S. Food and Drug Administration (FDA), Feb. 15, 2022. The Critical Path Institute (C-Path) congratulates Dr. Robert Califf on his Senate confirmation as Commissioner of the FDA. Dr. Califf has been...... -
August 17, 2021
Celebrating National Nonprofit Day and Sharing C-Path Updates
As we observe National Nonprofit Day and recognize the invaluable effort nonprofits put towards making an impact in our communities and across the globe, this seemed like a perfect opportunity to reshare some of the year’s accomplishments, championed by the talented and unshakeable team at C-Path, our consortia members and collaborators. Read our August 2021...... -
May 18, 2021
C-Path Request for Proposal for External Communications
Critical Path Institute (C-Path) is seeking a proposal, including timelines and budget, for external marketing, communications, public relations and related services. C-Path Request for Proposal for External Communications... -
April 6, 2021
C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate Director
C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science Consortium. D-RSC is currently engaged in several modeling projects of biomarkers and outcome measures, all at different stages in development and regulatory review, as well as development of a platform trial protocol for Duchenne and considering a new patient reported outcome instrument....... -
March 31, 2021
Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director
C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelerator-Data and Analytics Platform initiative. Dr. Bétourné will work with the RDCA-DAP team to expand its reach into new diseases areas accessing new data and enhancing C-Path’s relationships within the rare disease community. Dr. Bétourné holds......